Five [qnco]
Efficacy [qlco]
Safety [hcpp]
Adenoma [neop]
Prevention [topp]
celecoxib [orch, phsu]
Trial [resa]
Adenoma [neop]
Prevention [topp]
celecoxib [orch, phsu]
Trial [resa]
Examined [fndg]
Efficacy [qlco]
Safety [hcpp]
Cyclooxygenase II Inhibitor [orch, phsu]
celecoxib [orch, phsu]
Sporadic [tmco]
Colorectal Adenoma [neop]
Prevention [topp]
Patients [podg]
High Risk [qlco]
Colorectal Cancer [neop]
Trial [resa]
randomized [resa]
Subject [grup]
Receive [qlco]
placebo [topp]
celecoxib 200 MG [clnd]
Twice daily [tmco]
celecoxib 400 MG [clnd]
Twice daily [tmco]
Primary [qlco]
Study [mnob]
Safety [hcpp]
Efficacy [qlco]
treatment [ftcn]
Antitumor [qlco]
Indicated [fndg]
Increased [qnco]
CARDIOVASCULAR [bdsy]
adverse events [fndg]
Patients [podg]
treated [topp]
celecoxib [orch, phsu]
Compared [acty]
placebo [topp]
Patients [podg]
Extension [ftcn]
Adenoma [neop]
Prevention [topp]
celecoxib [orch, phsu]
Trial [resa]
plan treatment [inpr]
surveillance [ftcn]
Duration [tmco]
Study [mnob]
Medication [phsu]
stopped [qlco]
treatment duration [tmco]
With [qlco]
colonoscopy [diap]
Patients [podg]
treated [topp]
placebo [topp]
Arm [blor]
Cumulative [qlco]
Adenoma [neop]
P NOS [aapp, imft]
Receive [qlco]
Low dose [qnco]
celecoxib [orch, phsu]
P NOS [aapp, imft]
Receive [qlco]
High dose [qnco]
celecoxib [orch, phsu]
Cumulative [qlco]
Advanced adenomas [clna]
Take [hlca]
placebo [topp]
P NOS [aapp, imft]
Take [hlca]
Low dose [qnco]
celecoxib [orch, phsu]
P NOS [aapp, imft]
Take [hlca]
High dose [qnco]
celecoxib [orch, phsu]
Investigator [prog]
Reported [inpr]
treatment [ftcn]
emergent [idcn]
adverse events [fndg]
treatment [ftcn]
Group [idcn]
Categories [inpr]
Including [ftcn]
Renal [bpoc]
hypertensive [fndg]
Events [evnt]
gastrointestinal [spco]
Ulceration [patf]
Haemorrhage [patf]
Events [evnt]
Category [inpr]
CARDIOVASCULAR [bdsy]
Events [evnt]
Relative [famg]
placebo [topp]
2 5 [qnco]
mg% [qnco]
Twice daily [tmco]
celecoxib [orch, phsu]
mg% [qnco]
Twice daily [tmco]
celecoxib [orch, phsu]
secondary [neop]
Interaction [ftcn]
baseline [bodm]
History [ocdi]
Atherosclerotic heart disease NOS [dsyn]
study use [resa]
Drug [phsu]
CARDIOVASCULAR [bdsy]
adverse events [fndg]
P NOS [aapp, imft]
Inhibitory [acty]
celecoxib [orch, phsu]
Colorectal Adenoma [neop]
formation [biof]
Additional [ftcn]
Safety [hcpp]
Elevated [qlco]
CARDIOVASCULAR [bdsy]
adverse events [fndg]
Patients [podg]
Pre-existing [qlco]
Atherosclerotic heart disease NOS [dsyn]
